vimarsana.com
Home
Live Updates
GlycoMimetics, Inc. (NASDAQ:GLYC) Q3 2023 Earnings Call Transcript : comparemela.com
GlycoMimetics, Inc. (NASDAQ:GLYC) Q3 2023 Earnings Call Transcript
Operator: Good morning, and thank you for joining the GlycoMimetics Q3 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Related Keywords
San Diego ,
California ,
United States ,
Boston ,
Massachusetts ,
Dana Farber Cancer Institute ,
American ,
Debora Peralta ,
Harout Semerjian ,
Gaetano Bonifacio ,
John Horan ,
Christian Dinneen ,
Brian Hahn ,
Company Counsel At Glycomimetics ,
Washington University ,
American Society Of Hematology ,
Md Anderson Cancer Center ,
Alliance For Clinical Trials In Oncology ,
National Cancer Institute ,
Nasdaq ,
Global Medical Affairs ,
Pediatric Early Phase Clinical Trial Network ,
Blockchain Technology ,
Glycomimetics Inc ,
Call Transcript November ,
Christian Dinneen Long ,
Company Counsel ,
Chief Executive Officer ,
Chief Financial Officer ,
Edwin Rock ,
Chief Medical ,
American Society ,
Cancer Center ,
Dana Farber Cancer ,
Vice President ,
Clinical Trials ,
Pediatric Early Phase Clinical Trial ,
Boston Children ,
Roger Song ,
With The Worst Healthcare System ,
Learning Crypto ,
Maybei Ll ,
Boris Peaker ,
comparemela.com © 2020. All Rights Reserved.